Press release
Nonalcoholic Steatohepatitis Treatment Market to Witness a Staggering Growth between 2020 and 2030
Nonalcoholic steatohepatitis is a syndrome causes liver damage develops in the individuals who are not alcoholic. The primary mechanisms of nonalcoholic steatohepatitis are obesity, glucose intolerance, metabolic stress, inflammation, dyslipidemia and fibrosis. Nonalcoholic steatohepatitis can develop into cirrhosis and liver cancer. For the diagnosis of the nonalcoholic steatohepatitis, liver biopsy, imaging procedures and various types of blood tests including complete blood count, fasting blood sugar, liver enzyme tests etc. are required. The common nonalcoholic steatohepatitis treatment may include weight loss, type-2 diabetes treatment, a decrease of obesity etc. However, many drugs have been tested for the nonalcoholic steatohepatitis treatment only a few drugs such as vitamin E and pioglitazone showed a positive effect. Other drugs such as ursodeoxycholic acid, metformin, statins, orlistat and pentoxifylline showed only partially positive results. In the last several years the nonalcoholic steatohepatitis is continuously increasing in both developed and emerging countries. According to the “National Health and Nutrition Examination Survey,” the proportion of Nonalcoholic fatty liver disease among chronic liver diseases increased from 47% to 75% between 1988 and 2008 in the United States (US). The major elements that can be considered for the pathological protagonists of nonalcoholic steatohepatitis are oxidative stress, altered lipid metabolism adipose and pancreas tissues, bile acids, gut microbiota, bacterial endotoxins, and systemic chronic inflammation. However, more clinical studies and drug approvals by regulatory authorities are very much essential for nonalcoholic steatohepatitis treatment during forecast periods.To remain ‘ahead’ of your competitors, request for a sample here@
https://www.persistencemarketresearch.com/samples/31132
The nonalcoholic steatohepatitis treatment market can be segmented by drug types, test types and end-user.
Based on the drug types the nonalcoholic steatohepatitis treatment market can be segmented as
Vitamin E Supplement
Pioglitazone
Ursodeoxycholic Acid
Metformin
Statins
Pentoxifylline
Orlistat
Based on the test types the nonalcoholic steatohepatitis treatment market can be segmented as
Blood Tests
Complete Blood Count
Fasting Blood Sugar
Liver Enzyme And Liver Function Tests
Celiac Disease Screening Test
Tests For Chronic Viral Hepatitis (Hepatitis A, Hepatitis C And Others)
Lipid Profile, Which Measures Blood Fats, Such As Cholesterol And Triglycerides
Hemoglobin A1c, Which Shows How Stable Your Blood Sugar Is
Imaging Procedures
Abdominal Ultrasound
Magnetic Resonance Imaging (MRI)
Computerized Tomography (CT) Scanning
Magnetic Resonance Elastography
Transient Elastography
Liver Biopsy
Based on the end-user the nonalcoholic steatohepatitis treatment market can be segmented as
Hospitals
Diagnostic Centers
Specialized Clinics
Home Care Settings
Hospital Pharmacy
Drug Stores
Mail Order Pharmacy
Increasing incidents of obesity due to unhealthy diets and weight gain promotes the nonalcoholic steatohepatitis syndrome which drives the nonalcoholic steatohepatitis treatment market. Increasing prevalence of type 2 diabetes, obesity and dyslipidemia lead to nonalcoholic steatohepatitis disease, which drives the nonalcoholic steatohepatitis treatment market. However, the unavailable of the Food and Drug Administration (FDA) approved drugs for the nonalcoholic steatohepatitis treatment restrains the growth of the nonalcoholic steatohepatitis treatment market.
Due to the increasing prevalence of obesity, high cholesterol and type-2 diabetes the nonalcoholic steatohepatitis treatment market are expected high growth during forecasting periods. Unhealthy lifestyles, no exercises causes nonalcoholic steatohepatitis syndrome which will grow the nonalcoholic steatohepatitis treatment market. However, because of the unavailability of FDA approved drugs and medications expected to restrain the nonalcoholic steatohepatitis treatment market during forecast periods.
Request for Table of Content (TOC) @ https://www.persistencemarketresearch.com/toc/31132
North America is expected as the largest regional market share in the nonalcoholic steatohepatitis treatment market due to the presence of more number of market players, increasing awareness about nonalcoholic steatohepatitis treatment and marketing activities in the region followed by Europe. The nonalcoholic steatohepatitis treatment market is expected to grow fastest in the Asia Pacific may because of the increasing prevalence of obesity, high cholesterol and type-2 diabetes thus boosting the market growth. However, in the South Asian countries such as India and China, the opportunities to manufacture and distribute new nonalcoholic steatohepatitis treatment drugs is expected to be higher due to large population and increasing incidence of type-2 diabetes and obesity during forecasting periods.
Some of the Key Market Players operating in the nonalcoholic steatohepatitis treatment market are Allergan Inc., Galmed Pharmaceuticals Ltd., GENFIT, Gilead Sciences, Inc., Intercept Pharmaceuticals, Zydus and Cadila among others.
Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
U.S.A - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PersistenceMarketResearch.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonalcoholic Steatohepatitis Treatment Market to Witness a Staggering Growth between 2020 and 2030 here
News-ID: 2221098 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Blood
Global Blood Processing Consumables(CH 5) Market Size - By Product Type(blood ad …
Market Overview and Report Coverage
Blood Processing Consumables encompass various products and materials used in the collection, storage, processing, and transfusion of blood and blood components. This category includes items like blood bags, tubes, filters, and reagents essential for laboratories and hospitals in ensuring safe and effective blood management.
The current outlook for the Blood Processing Consumables market indicates robust growth driven by increasing healthcare needs, advancements in medical technology, and a…
Medical Blood Bag Market 2027 Global Analysis and Forecasts by Type (Single Bloo …
The medical blood bags are the instruments that are used to store, collect, transport, and transfuse blood and its components. The disposable blood bags replaced the use of glass bottles due to problems associated with the use of glass bottles including insufficient sterility, leading to contamination of the blood, and the development of air bubbles resulted in severe complications during blood transfusion.
Access Sample Report@: https://bit.ly/3rGMS4Q
Leading Players in the…
Global Blood coagulation analyzer Market, Blood coagulation analyzer Market 2020 …
The Blood coagulation analyzer market report provides a comprehensive view of global Blood coagulation analyzer industry. The study provides the industry overview with its growth analysis including CAGR, market shares, sales, gross margin, value, future trends, market opportunities etc. The study also includes analysis of historic data from 2015 to 2019 along with forecast from 2020 to 2025. Further, the Blood coagulation analyzer report contains drivers andrestraints of Blood coagulation…
Blood Bank (Blood Banking) Market 2019 Analysis By American Red Cross, Japan Red …
According to this study, over the next five years the Blood Bank (Blood Banking) market will register a 7.7% CAGR in terms of revenue, the global market size will reach US$ 40500 million by 2024, from US$ 26000 million in 2019.
Blood Bank (Blood Banking) Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion,…
Blood Bank (Blood Banking) Market Stay on The top of this growing business Indus …
Reports Monitor released a new Global Blood Bank (Blood Banking) Market research study with over 100 industry informative desk and Figures spread through Pages and an in-depth TOC on “Blood Bank (Blood Banking) Market”.
Global Blood Bank (Blood Banking) market 2019 research lays out the knowledge to achieve positive growth and presents different methods for maximizing your profit. The market study puts forward estimates for Global Blood Bank (Blood Banking) Market 2019 analysis and Forecast…
Blood Bank And Plasma Freezers Market Report 2018: Segmentation by Type (Common …
Global Blood Bank And Plasma Freezers market research report provides company profile for Follett, Glen Dimplex, Kirsch, LABCOLD, Lorne Laboratories, REMI GROUP, Telstar Group, LabRepCo, Helmer Scientific, Haier Bio-Medical, Panasonic Healthcare, Thermo Fisher, Dometic and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,…